# Observational melanoma studies recruiting: 109 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 109 trials that are observational for melanoma that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting observational melanoma studies: 109 rows for $5.45, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/observational/melanoma

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 109
- Recruiting or not yet: 109
- Read on: November 19, 2026

## Trials

The 25 newest of 109, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 13, 2026 | NCT07934550 | Prospective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical Outcomes | SkylineDx | Observational | Not yet recruiting | Melanoma (Skin Cancer), Gene Expression Profiling | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07934550) |
| November 3, 2026 | NCT07913412 | High-precision Radiosurgery Followed by Minimally Invasive Surgical Approach in Patients With High-prominence Uveal Melanoma: Modern... | University Hospital, Essen | Observational | Recruiting | Uveal Melanoma, High-risk Uveal Melanoma, Prominent Uveal Melanoma | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07913412) |
| October 20, 2026 | NCT07883954 | Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic Test | Sponsor not shown (see the record) | Observational | Recruiting | Melanoma | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07883954) |
| October 6, 2026 | NCT07861022 | Biomechanical Characterization of Skin Properties Using Impact Based-Analysis Method (IBAM) | Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris | Observational | Not yet recruiting | Melanoma (Skin Cancer), Skin Carcinoma | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861022) |
| September 8, 2026 | NCT07808164 | ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort | Tam Anh Research Institute | Observational | Recruiting | HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer), Gastric Carcinoma, Breast Cancer, Lung Cancer, Endometrial... | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07808164) |
| August 31, 2026 | NCT07794501 | Markers of Efficacy to Immunotherapy in Patients With Metastatic Melanoma | European Institute of Oncology | Observational | Not yet recruiting | Metastatic Melanoma | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07794501) |
| July 8, 2026 | NCT07691255 | MELanoma Brain Metastasis Treated With CYberknife | European Institute of Oncology | Observational | Recruiting | Melanoma (Skin Cancer) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691255) |
| July 2, 2026 | NCT07680699 | NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma | AC Camargo Cancer Center | Observational | Recruiting | Cutaneous Melanoma | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07680699) |
| June 9, 2026 | NCT07635732 | Urinary Microbiome as a Biomarker for Melanoma Diagnosis and Response Prediction to Systemic Tumour Therapy | Medical University of Graz | Observational | Recruiting | Melanoma Stage IV | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07635732) |
| May 13, 2026 | NCT07584291 | Liquid Biopsy Multi-Omics and Biomarker Development in Melanoma | Xijing Hospital | Observational | Recruiting | Melanoma (Skin Cancer) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07584291) |
| April 27, 2026 | NCT07552467 | Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors... | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Observational | Recruiting | Pancreatic Cancer, Breast Cancer, Lung Cancer, Sarcoma, Head and Neck Tumors, Glioblastoma, Colorectal Cancer, Melanoma | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07552467) |
| April 13, 2026 | NCT07524114 | Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) | University Health Network, Toronto | Observational | Recruiting | Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer, Genitourinary Cancer, Pancreatobiliary Cancer... | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07524114) |
| March 13, 2026 | NCT07469709 | A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks | Fondazione del Piemonte per l'Oncologia | Observational | Recruiting | Breast Cancer, Colo-rectal Cancer, Ovarian Cancer, Melanoma (Skin Cancer), Non-Small Cell Lung Cancer (MeSH Term... | 850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07469709) |
| March 2, 2026 | NCT07442292 | PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor | Peking University Cancer Hospital & Institute | Observational | Not yet recruiting | Lung Cancer (NSCLC), Lung Cancer (SCLC), Melanoma (Skin Cancer), Melanoma Metastatic, PD-L1, PET / CT | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07442292) |
| February 27, 2026 | NCT07437300 | Influence of a High-fiber Diet on the Microbiota and the Response to Immunotherapy in Patients Treated for Melanoma. | University Hospital, Grenoble | Observational | Not yet recruiting | Melanoma | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07437300) |
| January 29, 2026 | NCT07376512 | Predicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle Analysis | Centre Georges Francois Leclerc | Observational | Recruiting | Non-Small Cell Lung Cancer, Melanoma (Skin Cancer) | 378 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07376512) |
| January 21, 2026 | NCT07354152 | COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous... | Nantes University Hospital | Observational | Recruiting | Stage II Cutaneous Melanoma | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07354152) |
| January 8, 2026 | NCT07327489 | Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) | Elephas | Observational | Recruiting | Cancer, Immunotherapy, Advanced Solid Tumors Cancer, Bladder Cancer, TNBC, Triple Negative Breast Cancer, Colorectal... | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07327489) |
| January 5, 2026 | NCT07318051 | Sample Collection for Ongoing Research and Product Evaluation Study | Natera, Inc. | Observational | Recruiting | Breast Cancer, Lung Cancer, Muscle Invasive Bladder Cancer, Rectal Cancer, Pancreatic Cancer, Ovarian Cancer... | 9,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318051) |
| December 24, 2025 | NCT07302607 | Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021 | University Hospital, Strasbourg, France | Observational | Recruiting | Stage III Melanoma | 221 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07302607) |
| December 19, 2025 | NCT07293598 | Investigation of the ROle of faT and inflAmmaTory Cells in mElanoma | The Christie NHS Foundation Trust | Observational | Not yet recruiting | Melanoma (Skin Cancer) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07293598) |
| December 11, 2025 | NCT07277920 | Reflectance Confocal Microscopy and Molecular Correlation in Atypical Melanocytic Lesions | University of Modena and Reggio Emilia | Observational | Recruiting | Melanocytic Nevi, Melanoma (Skin Cancer), Next Generation Sequencing (NGS) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07277920) |
| December 5, 2025 | NCT07266142 | Prospective Collection of Clinical Data and Human Body Material (HBM) of Cutaneous Melanoma, Non Melanoma Patients and Healthy Controls.... | Universitaire Ziekenhuizen KU Leuven | Observational | Recruiting | Skin Cancer, Non-Melanoma, Skin Cancer Melanoma | 7,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07266142) |
| November 26, 2025 | NCT07251335 | Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active... | University of Modena and Reggio Emilia | Observational | Recruiting | Skin Melanoma, Cutaneous Melanoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07251335) |
| November 24, 2025 | NCT07246759 | Neutrophil Biomarker Test for Predicting Clinical Benefit From Immunotherapy Based on Flow Cytometry Analysis | OncoHost Ltd. | Observational | Not yet recruiting | Non Small Cell Lung Cancer (NSCLC), Melanoma (Skin Cancer), Triple Negative Breast Cancer (TNBC), RCC, Renal Cell... | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246759) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| University Health Network, Toronto | 6 |
| M.D. Anderson Cancer Center | 4 |
| Assistance Publique - Hôpitaux de Paris | 3 |
| Fundacion Clinic per a la Recerca Biomédica | 3 |
| Nantes University Hospital | 3 |
| European Institute of Oncology | 3 |
| National Cancer Institute (NCI) | 3 |
| University Hospital, Grenoble | 2 |
| University of Modena and Reggio Emilia | 2 |
| Region Skane | 2 |
| The Christie NHS Foundation Trust | 2 |
| St. Jude Children's Research Hospital | 2 |
| Mayo Clinic | 2 |
| Regina Elena Cancer Institute | 1 |
| Peking University Cancer Hospital & Institute | 1 |
| Technische Universität Dresden | 1 |
| Paradigm Health | 1 |
| Oregon Health and Science University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
| University Hospital, Strasbourg, France | 1 |
| Centre Hospitalier Universitaire Henri Mondor, Assistance Publique Hôpitaux de Paris | 1 |
| University Hospital, Rouen | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
| University of California, San Francisco | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 38 |
| France | 16 |
| Italy | 15 |
| Germany | 9 |
| Canada | 8 |
| Spain | 8 |
| United Kingdom | 6 |
| Australia | 4 |
| Austria | 3 |
| Puerto Rico | 3 |
| Belgium | 2 |
| Sweden | 2 |
| China | 2 |
| Vietnam | 1 |
| Switzerland | 1 |
| Israel | 1 |
| Singapore | 1 |
| New Zealand | 1 |
| Saudi Arabia | 1 |
| Brazil | 1 |
| Russia | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Uzbek restaurants in the United States](https://specstream.ai/data/businesses/uzbek-restaurants/united-states)
- [Accounting firms in the United States](https://specstream.ai/data/businesses/accounting-firms/united-states)
- [Awning suppliers in the United States](https://specstream.ai/data/businesses/awning-suppliers/united-states)
- [Bathtub and sink repair companies in the United States](https://specstream.ai/data/businesses/bathtub-and-sink-repair-companies/united-states)
- [Career counseling services in the United States](https://specstream.ai/data/businesses/career-counseling-services/united-states)
- [Cooking schools in the United States](https://specstream.ai/data/businesses/cooking-schools/united-states)
